Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

ARTEMIS AcceleRating the Translation of virtual twins towards a pErsonalised Management of fatty lIver patients

Coordinator
Matical Innovation SL, Spain
Runs
1 January 2024 to 31 December 2027
Status
Running
EU funding
€9.4m
Total cost
€9.4m
Partners
21 organisations in 9 countries
Type
Research and Innovation Action
Grant agreement
101136299

What the project is doing

In the project's own words, from its summary on CORDIS.

The ARTEMIs project aims to consolidate existing computational mechanistic and machine-learning models at different scales to deliver ‘virtual twins’ embedded in a clinical decision support system (CDSS). The CDSS will provide clinically meaningful information to clinicians, for a more personalised management of the whole spectrum of Metabolic Associated Fatty Liver Disease (MAFLD). MAFLD, with an estimated prevalence of about 25%, goes from an undetected sleeping disease, to inflammation (hepatitis), to fibrosis development (cirrhosis) and/or hepatocellular carcinoma (HCC), decompensated cirrhosis and HCC being the final stages of the disease.

However, many MAFLD patients do not die from the liver disease itself, but from cardiovascular comorbidities or complications. The ARTEMIs will contribute to the earlier management of MAFLD patients, by prognosing the development of more advanced forms of the disease and cardiovascular comorbidities, promoting active surveillance of patients at risk. The system will predict the impact of novel drug treatments or procedures, or simply better life habits.

The system will therefore not only serve as a clinical decision aid tool, but also as an educational tool for patients, to promote better nutritional and lifestyle behaviors. In more advanced forms of the disease, therapeutic interventions include TIPPS to manage portal hypertension, partial hepatectomy, partial or complete liver transplant. ARTEMIs will contribute to predict per- or post-intervention heart failure, building on existing microcirculation hemodynamics models.

The model developers will benefit from a large distributed patient cohort and data exploration environment to identify patterns in data, draw new theories on the liver-heart metabolic axis and validate the performance of their models. The project includes a proof-of-concept feasibility study assessing the utility of the integrated virtual twins and CDSS in the clinical context.

Topics

Who is involved

OrganisationCityCountryRole
Matical Innovation SLMadridSpainCoordinator
Medizinische Universitaet WienWienAustriaParticipant
Cliniques Universitaires Saint-Luc ASBLBruxelles / BrusselBelgiumParticipant
European Liver Patients AssociationBruxelles / BrusselBelgiumParticipant
Betthera SroHradec KraloveCzechiaParticipant
Albert-Ludwigs-Universitaet FreiburgFreiburgGermanyParticipant
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
Deutsches Krebsforschungszentrum HeidelbergHeidelbergGermanyParticipant
Universitaet LeipzigLeipzigGermanyParticipant
Universitatsklinikum HeidelbergHeidelbergGermanyParticipant
Universitatsklinikum JenaJenaGermanyParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad ValencianaValenciaSpainParticipant
Assistance Publique Hopitaux De ParisParisFranceParticipant
Bc PlatformsToulouseFranceParticipant
Fondation Cardiometabolisme NutritionParisFranceParticipant
Institut National De Recherche En Informatique Et AutomatiqueLe Chesnay CedexFranceParticipant
Medical Research Infrastructure Development and Health Services Fund by the Sheba Medical CenterRamat GanIsraelParticipant
Universita Degli Studi Di Roma La SapienzaRomaItalyParticipant
Bournemouth UniversityPooleUnited KingdomAssociatedpartner
Imperial College of Science Technology and MedicineLondonUnited KingdomAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI